المؤلفون: N Roescher, JM Prins, JTM van der Meer, HI Bax, R Soetekouw, MGJ de Boer, LBS Gelinck, JJ Oosterheert, MA van Agtmael, M Berrevoets, DTP Buis, CH van Werkhoven, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, E Jong, AJJ Lammers, E Sieswerda, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, KCE Sigaloff, E Botman, A Van den Broek, L Buitenhuis, E Buitenwerf, A S Cents, N Engels, J L J Hanssen, A J Meinders, F P N Mollema, L Nagelmaker, M L M van Doorn-Schepens, P Thomopoulos, M Timmer, B van der Wiel

المصدر: BMJ Open, Vol 13, Iss 4 (2023)

مصطلحات موضوعية: Medicine

وصف الملف: electronic resource

Relation: https://bmjopen.bmj.com/content/13/4/e068295.full; https://doaj.org/toc/2044-6055

URL الوصول: https://doaj.org/article/cf2fa20a75a4412a9dbd8b21a6ce2c68

المؤلفون: DTP Buis, CH van Werkhoven, MA van Agtmael, HI Bax, M Berrevoets, MGJ de Boer, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, LBS Gelinck, E Jong, AJJ Lammers, JTM Van der Meer, JJ Oosterheert, E Sieswerda, R Soetekouw, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, JM Prins, KCE Sigaloff

المساهمون: Infectious diseases, AII - Infectious diseases, Health Economics and Health Technology Assessment, APH - Mental Health, APH - Methodology, Internal medicine, AII - Inflammatory diseases, Psychiatry, Gastroenterology and hepatology, VU University medical center, Medical Microbiology & Infectious Diseases, Internal Medicine, Pathology

المصدر: BMJ open, 13(4):e068295. BMJ Publishing Group
BMJ Open, 13(4):e068295, 1-26. BMJ Publishing Group
Collaborators SAFE-trial study group 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. e068295 . https://doi.org/10.1136/bmjopen-2022-068295
BMJ Open, 13(4). BMJ Publishing Group
BMJ Open, 13(4):e068295. BMJ Publishing Group
Buis, D T P, Van Werkhoven, C H, Van Agtmael, M A, Bax, H I, Berrevoets, M, De Boer, M G J, Bonten, M J M, Bosmans, J E, Branger, J, Douiyeb, S, Gelinck, L B S, Jong, E, Lammers, A J J, Van Der Meer, J T M, Oosterheert, J J, Sieswerda, E, Soetekouw, R, Stalenhoef, J E, Van Der Vaart, T W, Bij De Vaate, E A, Verkaik, N J, Van Vonderen, M G A, De Vries, P J, Prins, J M & Sigaloff, K C E 2023, ' Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial) : Protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment ', BMJ Open, vol. 13, no. 4, e068295, pp. 1-26 . https://doi.org/10.1136/bmjopen-2022-068295

مصطلحات موضوعية: internal medicine, SDG 3 - Good Health and Well-being, General Medicine, bacteriology, infectious diseases

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af21151bb8a9b51016d71c3255ece501
https://pure.amc.nl/en/publications/safe-shortening-of-antibiotic-treatment-duration-for-complicated-staphylococcus-aureus-bacteraemia-safe-trial(7669693a-f906-448b-b63f-7135141cbf37).html

المؤلفون: Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Wielders CCH; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., den Boer H; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Langerak D; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Vogel M; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Witteveen S; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., de Haan A; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Bos J; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., van Westreenen M; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Notermans DW; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Hendrickx APA; Centre for Infectious Disease Control (CIb), National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.

مؤلفون مشاركون: participating laboratories, SWAB Working Group Surveillance of Antimicrobial Resistance

المصدر: Microbiology spectrum [Microbiol Spectr] 2024 Sep 24, pp. e0114224. Date of Electronic Publication: 2024 Sep 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2165-0497 (Electronic) Linking ISSN: 21650497 NLM ISO Abbreviation: Microbiol Spectr Subsets: MEDLINE

المؤلفون: Dräger S; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, the Netherlands; Department of Internal Medicine, University Hospital Basel, Basel, Switzerland. Electronic address: s.drager@erasmusmc.nl., Ewoldt TMJ; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, the Netherlands; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Abdulla A; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, the Netherlands., Rietdijk WJR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Institutional Affairs, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Center, Rotterdam, the Netherlands., van Vliet P; Department of Intensive Care Medicine, Haaglanden Medical Center, The Hague, the Netherlands., Purmer IM; Department of Intensive Care Medicine, Haga Hospital, The Hague, the Netherlands., Osthoff M; Department of Internal Medicine, University Hospital Basel, Basel, Switzerland., Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands; Rotterdam Clinical Pharmacometrics Group, Rotterdam, the Netherlands., Endeman H; Department of Intensive Care Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.

مؤلفون مشاركون: DOLPHIN investigators

المصدر: Journal of critical care [J Crit Care] 2024 Sep 13, pp. 154904. Date of Electronic Publication: 2024 Sep 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: W.B. Saunders Country of Publication: United States NLM ID: 8610642 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8615 (Electronic) Linking ISSN: 08839441 NLM ISO Abbreviation: J Crit Care Subsets: MEDLINE

المؤلفون: Hassanzai M; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Postal box 2040, Rotterdam, 3000 CA, The Netherlands., Adanç F; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Koch BCP; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; CATOR: Center for Antimicrobial Treatment Optimization Rotterdam, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, Rotterdam, The Netherlands., van Oldenrijk J; Department of Orthopaedics and Sports Medicine, Erasmus MC University Medical Center, Rotterdam, The Netherlands., de Bruin JL; Department of Vascular Surgery, Erasmus University Medical Center, Rotterdam, The Netherlands., de Winter BCM; Department of Hospital Pharmacy, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; CATOR: Center for Antimicrobial Treatment Optimization Rotterdam, The Netherlands., van Onzenoort HAW; Department of Pharmacy, Radboud University Medical Centre, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center+, Maastricht, The Netherlands.

المصدر: Therapeutic advances in infectious disease [Ther Adv Infect Dis] 2023 Dec 13; Vol. 10, pp. 20499361231214901. Date of Electronic Publication: 2023 Dec 13 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 101606715 Publication Model: eCollection Cited Medium: Print ISSN: 2049-9361 (Print) Linking ISSN: 20499361 NLM ISO Abbreviation: Ther Adv Infect Dis Subsets: PubMed not MEDLINE

المؤلفون: Sarink MJ; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Bode LGM; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Croughs P; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., de Steenwinkel JEM; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., van Westreenen M; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Vogel M; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands., Yusuf E; Department of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center, Rotterdam, the Netherlands.

المصدر: Journal of clinical microbiology [J Clin Microbiol] 2023 Aug 23; Vol. 61 (8), pp. e0046323. Date of Electronic Publication: 2023 Jul 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: Escherichia coli* , Staphylococcus aureus*, Humans ; Drug Resistance, Bacterial ; Anti-Bacterial Agents/pharmacology ; Bacteria ; Pseudomonas aeruginosa ; Microbial Sensitivity Tests

المؤلفون: Wammes LJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.; Present address: Department of Medical Microbiology, LUMC Center for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Voor In 't Holt AF; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands., Klaassen CHW; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands., Vos MC; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands., Severin JA; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. j.severin@erasmusmc.nl.

المصدر: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology [Eur J Clin Microbiol Infect Dis] 2023 Aug; Vol. 42 (8), pp. 993-999. Date of Electronic Publication: 2023 Jun 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Country of Publication: Germany NLM ID: 8804297 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1435-4373 (Electronic) Linking ISSN: 09349723 NLM ISO Abbreviation: Eur J Clin Microbiol Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Enterococcus faecium* , Vancomycin-Resistant Enterococci* , Gram-Positive Bacterial Infections*/diagnosis , Gram-Positive Bacterial Infections*/epidemiology , Gram-Positive Bacterial Infections*/microbiology, Humans ; Vancomycin ; Contact Tracing ; Retrospective Studies ; Anti-Bacterial Agents/therapeutic use

المؤلفون: Buis D; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands d.t.p.buis@amsterdamumc.nl., van Werkhoven CH; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., van Agtmael MA; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Bax HI; Department of Internal Medicine, Section of Infectious Diseases, Erasmus Medical Center, Rotterdam, The Netherlands.; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands., Berrevoets M; Department of Internal Medicine, Elisabeth twee-steden Hospital, Tilburg, The Netherlands., de Boer M; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands., Bonten M; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands., Bosmans JE; Department of Health Sciences, Faculty of Science, Amsterdam Public Health research institute, VU University Amsterdam, Amsterdam, The Netherlands., Branger J; Department of Internal Medicine, Flevohospital, Almere, The Netherlands., Douiyeb S; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Gelinck L; Department of Internal Medicine, Haaglanden Medisch Centrum, Den Haag, The Netherlands., Jong E; Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, The Netherlands., Lammers A; Department of Internal medicine & Infectious Diseases, Isala Zwolle, Zwolle, The Netherlands., Van der Meer J; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Oosterheert JJ; Department of Internal Medicine, Infectious Diseases, UMC Utrecht, Utrecht, The Netherlands., Sieswerda E; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Department of Medical Microbiology, UMC Utrecht, Utrecht, The Netherlands., Soetekouw R; Department of Internal Medicine, Spaarne Gasthuis, Haarlem/Hoofddorp, The Netherlands., Stalenhoef JE; Department of Internal Medicine, OLVG, Amsterdam, The Netherlands., Van der Vaart TW; Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht, The Netherlands.; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands., Bij de Vaate EA; Department of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC, Rotterdam, The Netherlands., Van Vonderen M; Medisch Centrum Leeuwarden, Leeuwarden, The Netherlands., De Vries PJ; Department of Internal Medicine, Tergooi Hospital, Hilversum, The Netherlands., Prins JM; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands., Sigaloff K; Department of Internal Medicine, Division of Infectious Diseases, Amsterdam Institute for Infection and Immunity, Amsterdam UMC Locatie VUmc, Amsterdam, The Netherlands.

مؤلفون مشاركون: Collaborators SAFE-trial study group

المصدر: BMJ open [BMJ Open] 2023 Apr 21; Vol. 13 (4), pp. e068295. Date of Electronic Publication: 2023 Apr 21.

نوع المنشور: Clinical Trial Protocol; Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE

مواضيع طبية MeSH: Staphylococcal Infections*/drug therapy , Staphylococcal Infections*/microbiology , Bacteremia*/microbiology, Adult ; Humans ; Anti-Bacterial Agents ; Duration of Therapy ; Staphylococcus aureus ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic

المؤلفون: Wahadat AR; Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands., Tanis W; Department of Cardiology, Haga Teaching Hospital, The Hague, The Netherlands., Galema TW; Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands., Swart LE; Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., van Leeuwen WJ; Department of Cardiothoracic Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands., Schurink CAM; Department of Medical Microbiology and Infectious Diseases, Erasmus Medical Centre, Rotterdam, The Netherlands.; Department of Internal Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., van Dalen B; Department of Cardiology, Franciscus Gasthuis & Vlietland Hospital, Rotterdam, The Netherlands., Zoet-Nugteren S; Department of Cardiology, Ikazia Hospital, Rotterdam, The Netherlands., Gurlek C; Department of Cardiology, Admiral de Ruyter Hospital, Goes, The Netherlands., Budde RPJ; Department of Radiology and Nuclear Medicine, Erasmus Medical Centre, Rotterdam, The Netherlands., Roos-Hesselink JW; Department of Cardiology, Erasmus Medical Centre, Rotterdam, The Netherlands. j.roos@erasmusmc.nl.

المصدر: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation [Neth Heart J] 2023 Jan; Vol. 31 (1), pp. 29-35. Date of Electronic Publication: 2022 Jul 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Bohn Stafleu van Loghum Country of Publication: Netherlands NLM ID: 101095458 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1568-5888 (Print) Linking ISSN: 15685888 NLM ISO Abbreviation: Neth Heart J Subsets: PubMed not MEDLINE

المؤلفون: Dix LML; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands. Electronic address: l.dix@erasmusmc.nl., de Goeij I; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Manintveld OC; Department of Cardiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands; Erasmus MC Transplant Institute, Rotterdam, The Netherlands., Severin JA; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands., Verkaik NJ; Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands.

المصدر: American journal of infection control [Am J Infect Control] 2022 Dec; Vol. 50 (12), pp. 1392-1394. Date of Electronic Publication: 2022 May 13.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 8004854 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3296 (Electronic) Linking ISSN: 01966553 NLM ISO Abbreviation: Am J Infect Control Subsets: MEDLINE

مواضيع طبية MeSH: Heart-Assist Devices*/adverse effects , Pseudomonas Infections* , Prosthesis-Related Infections*, Humans ; Pseudomonas aeruginosa ; Toilet Facilities